Sofie Qiao

AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018.

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu.

Cenova Ventures is an independent venture capital firm headquartered in China. The firm was founded by Dr. Jun Wu in 2010.

Novoasis Investment Ltd. provides investment services. The private company is based in Hong Kong, Hong Kong.

Shanghai Cenova Biomedicine Venture Capital Invt Co. Ltd. invests in companies located in China. The fund invests in sectors related to biotechnology and health care. It provides financing for start-up and growth stage companies.

ProteomTech, Inc. develops protein therapeutics. The private company is based in Emeryville, CA.

Chembridge Research Laboratories, Inc. discovers molecule drugs. The private company is based in San Diego, CA. The company was founded by Charles Mikel.

Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA.

Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom.

Suzhou Jingyi Healthcare Equipment Co., Ltd. was founded in 2011 by Yi Hua Ning and is based in Suzhou, China. The Chinese company is an innovative high-tech medical equipment company that specializes in the research and development, production, and sales of deep brain stimulation systems. The company has complete independent intellectual property rights and are constantly developing new technologies and products. The company's goal is to become a medical equipment company with international high-end technology and competitiveness, allowing more patients to benefit from high-tech medical treatment.

ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019.

Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA.

Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom.

Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA.

Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK.

Shanghai Birdie Biotech Ltd. is a private company that specializes in biotechnology research and development. The company is based in Shanghai, China.

Etongonline Shanghai Medical Consulting Co. Ltd. provides third-party health management services. The private company is based in Shanghai, China.

IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.

Boxer Capital LLC (Boxer Capital) is a venture capital subsidiary of Tavistock Group, Inc. founded in 2005 by Chris Fuglesang and Aaron I. Davis. The firm is headquartered in San Diego, California.

Part of Thermo Fisher Scientific, Inc., Life Technologies International BV manufactures analytical instruments.

Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.

ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin.

Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA.

Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

NanoCellect Biomedical, Inc. develops flow cytometry and cell sorting technology solutions for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. Its products include wolf cell sorter and N1 single cell dispenser. The company was founded by Nate Heintzman and Yuhwa Lo in 2009 and is headquartered in San Diego, CA.